Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Wave Life Sciences stock

Learn how to easily invest in Wave Life Sciences stock.

Wave Life Sciences Ltd is a biotechnology business based in the US. Wave Life Sciences shares (WVE) are listed on the NASDAQ and all prices are listed in US Dollars. Wave Life Sciences employs 235 staff and has a trailing 12-month revenue of around $40.3 million.

How to buy shares in Wave Life Sciences

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – WVE – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Wave Life Sciences stock price (NASDAQ: WVE)

Use our graph to track the performance of WVE stocks over time.

Wave Life Sciences shares at a glance

Information last updated 2022-10-02.
Latest market close$3.66
52-week range$1.16 - $5.22
50-day moving average $3.17
200-day moving average $2.62
Wall St. target price$8.43
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.15

Buy Wave Life Sciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Wave Life Sciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Wave Life Sciences price performance over time

Historical closes compared with the close of $3.66 from 2022-10-05

1 week (2022-09-29) 3.39%
1 month (2022-09-07) 18.83%
3 months (2022-07-07) -10.29%
6 months (2022-04-07) 46.40%
1 year (2021-10-07) -22.62%
2 years (2020-10-07) -59.20%
3 years (2019-10-07) 19.04
5 years (2017-10-06) 25

Wave Life Sciences financials

Revenue TTM $40.3 million
Gross profit TTM $-73,644,000
Return on assets TTM -36.92%
Return on equity TTM -350.54%
Profit margin -297.98%
Book value $0.36
Market capitalisation $313.4 million

TTM: trailing 12 months

Wave Life Sciences share dividends

We're not expecting Wave Life Sciences to pay a dividend over the next 12 months.

Wave Life Sciences share price volatility

Over the last 12 months, Wave Life Sciences's shares have ranged in value from as little as $1.16 up to $5.22. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Wave Life Sciences's is -0.5625. This would suggest that Wave Life Sciences's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Wave Life Sciences has bucked the trend.

Wave Life Sciences overview

Wave Life Sciences Ltd. , a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional proteins, or modulate protein expression. The company also develops WVE-004, a C9orf72 molecule for the treatment of amyotrophic lateral sclerosis and frontotemporal dementia; WVE-003, a mutant huntingtin SNP3 molecule for the treatment of Huntington's disease; WVE-N531, an Exon 53 molecule for the treatment of Duchenne muscular dystrophy; and ATXN3, a discovery stage program for the treatment of spinocerebellar ataxia 3, as well as multiple preclinical programs for CNS disorders. In addition, it focuses on developing GalNAc-conjugated AIMers to treat hepatic indications comprising Alpha-1 antitrypsin deficiency (AATD); and two preclinical programs, such as Usher syndrome type 2A (USH2A) and retinitis pigmentosa due to a P23H mutation in the RHO gene (RhoP23H) for the treatment of retinal diseases. It has collaboration agreements with Pfizer Inc. , Takeda Pharmaceutical Company Limited, University of Oxford, University of Massachusetts, Western Washington University, Grenoble Institute of Neurosciences, IRBM S.

Frequently asked questions

What percentage of Wave Life Sciences is owned by insiders or institutions?
Currently 16.259% of Wave Life Sciences shares are held by insiders and 79.27% by institutions.
How many people work for Wave Life Sciences?
Latest data suggests 235 work at Wave Life Sciences.
When does the fiscal year end for Wave Life Sciences?
Wave Life Sciences's fiscal year ends in December.
Where is Wave Life Sciences based?
Wave Life Sciences's address is: Marina One East Tower, Singapore, Singapore, 018936
What is Wave Life Sciences's ISIN number?
Wave Life Sciences's international securities identification number is: SG9999014716
What is Wave Life Sciences's CUSIP number?
Wave Life Sciences's Committee on Uniform Securities Identification Procedures number is: Y95308105

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site